-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/congestive-heart-failure-medicines_research.pdf
March 01, 2010 - Because of concern that some patients might receive H-ISDN late in their illness as a
salvage treatment … for very severe HF that had proven refractory to other
treatments. … A
comparison of enalapril with hydralazine-
isosorbide dinitrate in the treatment of
chronic congestive … A review of uses of
health care utilization databases for
epidemiologic research on therapeutics. … Mortality hazard ratios for receipt of selected heart failure therapies or combinations versus no therapy
-
effectivehealthcare.ahrq.gov/sites/default/files/depression-horizon-scan-high-impact-1306.pdf
October 01, 2014 - Overall high-impact potential: deep brain stimulation (Reclaim DBS Therapy or
Libra DBS) for treatment-resistant … and psychotherapy as first- and
second-line therapies and electroconvulsive therapy or repetitive … They cited suboptimal current treatments, lack of an FDA-approved
treatment for this condition, and … DBS therapy is incompatible with some other device-
based depression treatments. … of Psychotic Depression
Deep Brain Stimulation (Reclaim DBS Therapy or Libra DBS) for Treatment-Resistant
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND__0399_01-07-2011.pdf
January 01, 2011 - Comparator(s): Comparisons of the above therapeutic interventions. … transarterial chemoembolization
(TACE) and radioembolization (RE)
Comparator(s): Comparisons of the above therapeutic … Comparator(s): Comparisons of the above therapeutic interventions. … What is the comparative effectiveness of local treatments for unresectable liver
metastases and unresectable … For metastatic liver disease, local therapy may be used in an attempt to prolong survival and/or to
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/treatment-resistant-depression_executive.pdf
September 01, 2011 - as
therapies for patients with TRD: electroconvulsive
therapy (ECT), repetitive transcranial magnetic … Comparisons of these nonpharmacologic
therapies are our main interest. … How do the efficacy, effectiveness, or
harms of treatment with nonpharmacologic
treatments for TRD differ … Direct comparisons of treatment strategies, holding
consistent any coexisting or concomitant therapies … When
ongoing treatment is uncontrolled and reflects a variety
of treatments—e.g., some patients continue
-
effectivehealthcare.ahrq.gov/products/gastric-cancers/protocol
-
effectivehealthcare.ahrq.gov/products/menopause/research-protocol
-
effectivehealthcare.ahrq.gov/sites/default/files/back-pain-treatment_disposition-comments.pdf
February 29, 2016 - Osteopathic manual treatment and
ultrasound therapy for chronic low back
pain: a randomized controlled … A wide variety of
treatment modalities have been explored
for their potential therapeutic effect for … Indeed, multimodal
pain therapy is a now a well-recognized
treatment strategy for back pain, and this … As a result there continues to
be no clear physical therapy (PT)
treatments, per the literature regarding … Unfortunately, even for treatments
aimed at improving function such
as exercise, behavioral therapies
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/breast-cancer-risk-reduction_research.pdf
October 25, 2010 - /therapeutic benefits for many diseases”
“I like this idea [weight loss as therapy] because of the … /therapeutic benefits for many diseases. … Cancer risk after exposure to
treatments for ovulation induction. … Chemoprevention and
therapeutic treatment of BRCA1 associated
with mammary tumors.
171. 5R03CA136014 … Journal of
Pharmacology & Experimental Therapeutics
2009 Nov;331(2):563-573.
215.
-
effectivehealthcare.ahrq.gov/sites/default/files/s16.pdf
October 01, 2007 - of
individual patients or weighing the implications of particular poli-
cies affecting medical therapies … clinical and policy
decisions at different levels of the health care system, as
illustrated in Table 1 for treatments … randomization provides against sources of bias and
confounding that often affect observational studies, where
treatments … Decisions Relevant to Medical Therapies
(Example: Therapy for Osteoporosis)
Drug approval—Is slow release … Long-term adherence to
evidence-based secondary prevention therapies in coronary artery dis-
ease.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/arthritis-psoriatric_research-protocol.pdf
December 06, 2010 - above, as these are new approved treatments since the time of the
literature searches for the first … of patients based on stage of disease, history of prior
therapy, demographics, concomitant therapies … versus any of these same
treatments may result in intermediate outcomes such as symptoms, joint damage … articles relevant to each key question, we began with a focused
MEDLINE search on pharmacological treatments … However, if we find a sufficient number (three or more) of similar studies of
factors influencing the treatments
-
effectivehealthcare.ahrq.gov/sites/default/files/08_functional_limitations_potential_high_impact_2012-12-10.pdf
January 01, 2012 - uncontrolled by other therapeutic agents. … would be very accepting of this therapy because of the lack of other effective treatments,
marking … patients an effective therapy option within the current treatment model. … Edison (NJ): Oceana
Therapeutics, Inc.; 2010 Dec 2. 65 p.
48. … Oceana Therapeutics announces U.S. launch of
Solesta, the only nonsurgical FDA approved
treatment
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/chronic-cough_executive.pdf
March 01, 2014 - In the majority
of cases, symptomatic treatment consists of antitussive
therapy to decrease cough frequency … Antitussive treatments vary in mechanism of action. … therapies. … Given the changes in both available therapies and the
diagnosis and treatment of underlying etiologies … Focusing on nonspecific or
symptomatic treatments to the exclusion of treatments
aimed at specific
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-anemia_executive.pdf
May 01, 2006 - Tumor type, treatment
regimen, and history of prior cancer
therapy influence the risk and severity of … Effectiveness Reviews,
the program supports systematic
appraisals of existing scientific
evidence regarding treatments … How do alternative thresholds for initiating
treatment or alternative criteria for discontinuing
therapy … Thresholds for initiating treatment or
criteria for discontinuing therapy
Three unblinded randomized … No trials compared criteria for discontinuing
therapy.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/asd-interventions-disposition.pdf
May 26, 2017 - The first paragraph summarizes goals of treatment and
complication of treatment (and outcome) by comorbid … Introduction The introduction is concise, well written and well referenced. for both the
medical therapies … and the sensory therapies the writing is focused on
these therapies; there is not a need for extensive … the therapy does not "work". … TEP
Reviewer #4
Discussion/Con
clusion
The review of sensory therapies is also concise and on target
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/autism-medical-update_research-protocol.pdf
February 16, 2016 - b) Is the effectiveness of the therapies reviewed affected by co-interventions or prior
treatment … targeting sensory challenges as driving outcomes, either
within a single treatment or across treatments … [sh] OR therapeutics[mh] OR teaching[mh] OR psychotherapy[mh] OR
treatment outcome[mh]
7275093 …
5 (treatment[tiab] OR therapy[tiab] OR intervention[tiab] OR “control group”[tiab]
OR … "[Mesh]) OR ( "drug therapy" [Subheading] OR "Medication
Therapy Management"[Mesh] )
2368930
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/gerd-disposition-120104.pdf
April 01, 2011 - For example the surgical
vs endoscopic treatments specifically describes result of one study,
but doesn … Particular striking in the medical versus surgical
treatments section. … ES-2, Medical versus surgical treatments, Paragraph 1 -
Consider including a statement regarding the … Summary
For the most part, the report provides a nice summary of the pros and
cons related to various treatments … Patients with more
severe nocturnal heartburn symptoms at baseline experienced
greater therapeutic
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/genitourinary-symptoms-protocol_0.pdf
July 10, 2023 - The range of GSM treatments has increased substantially in recent years. … In
addition to traditional therapies (vaginal or systemic estrogen, vaginal lubricants and
moisturizers … Which treatments show improvement
for which symptoms? … ,
Laser therapy for
anatomic areas other
than the vagina,
Pelvic floor physical
therapy for … -available
treatments.
19
5-3-2023 Methods (Table 1.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND-555-09-03-2013.pdf
January 01, 2013 - cardiovascular outcomes (e.g., heart disease, stroke), comorbidities (e.g., depression,
anxiety), adherence to treatment … Does educational counseling help patients improve glucose control and
adherence to treatment? … Behavioral
interventions can also include Cognitive Behavioral Therapy, relaxation-based interventions … AHRQ systematic reviews were identified:
• An archived 2004 AHRQ report entitled: Use of Behavioral Therapies … for Treatment of Medical
Disorders: Part 1 – Impact on Management of Patients with Diabetes Mellitus
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-267-adhd-executive-summary.pdf
March 01, 2024 - • We found little evidence that combination therapies of medication plus
psychosocial therapies … effectiveness and safety
information is limited and more research is needed to help choose between
treatments … Across studies, medication therapy evaluations reported more adverse events
than non-medication interventions … Medication therapy remains a central
treatment modality, though with a risk of side effects, even as … evidence for non-
pharmacological therapies strengthen and as novel treatment approaches emerge.
-
effectivehealthcare.ahrq.gov/sites/default/files/depression-horizon-scan-high-impact-1312.pdf
October 01, 2014 - therapy or repetitive
transcranial magnetic stimulation as second- and third-line therapies for BPD … DBS is expected to be positioned as an additional
therapeutic option for patients who have treatment-resistant … They cited suboptimal treatments, lack of an FDA-approved
treatment for this condition, and the condition … DBS therapy is incompatible and
contraindicated with some other device-based depression treatments, … , which could provide a therapeutic
advantage over standard antidepressants with delayed therapeutic